Oncology Exchange
Group Profile
- ONCOLOGY EXCHANGE (ONCO X) is designing a comprehensive, yet easy to use technology solution to expand patient access to the vast global oncology science and practices already in play.
Recent Activity
June 14
June 10
Charles Decuir @Oncology Exchange published Advarra expands Gene Therapy Ready network with 500+ sites
2 years ago
June 07
Charles Decuir @Oncology Exchange published Newly identified protein could become target for cancer immunotherapy
2 years ago
Charles Decuir @Oncology Exchange published Investors buoyed by positive data for Immutep’s immunotherapy
2 years ago
Charles Decuir @Oncology Exchange published FDA Approves First KRAS-Targeted Therapy, Lumakras, for NSCLC
2 years ago
Charles Decuir @Oncology Exchange published Patient is cancer-free after robotic-assisted surgery
2 years ago
May 17
Charles Decuir @Oncology Exchange: Metastatic colon cancer patient saved by aggressive treatmenthttps://www.bizjournals.com/k...
2 years ago
Charles Decuir @Oncology Exchange: Exploring Novel Mechanisms of Action–Then and Nowhttps://www.cancernetwork.co...
2 years ago
Charles Decuir @Oncology Exchange: Artificial intelligence-radiologist combo reduces missed lung cancer diagnoses by 60%https://www.radiologybusines...
2 years ago
Recent Posts

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities
A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor...
read more

Novel Therapy Shows Promise in Group of Patients with Metastatic Colon Cancer
Patients with HER2-expressing metastatic colorectal cancer appeared to achieve durable and promising...
read more
